Tablet comprising a delayed release coating

A delayed release tablet comprising:

• (i) a core comprising an active ingredient selected from the group consisting of oxybutynin hydrochloride, propranolol hydrochloride, buspiron hydrochloride, niacin, cetirizin hydrochloride, cerivastin sodium, metoprolol fumarate, and alendronate sodium, and conventional excipients;
• and
• (ii) a coating consisting essentially by weight, based on the coating weight, of 20 to 85% of a water-insoluble, water-permeable film-forming polymer, of 10 to 75% of a water-soluble polymer and 5 to 30% of a plasticizer, exhibiting a dissolution profile such that after 2 hours, from 5 to 40% of the active ingredient is released, after 4 hours, from 10 to 60% of the active ingredient is released, after 12 hours, from 50 to 98% of the active ingredient is released, after 24 hours, more than 80% of the active ingredient is released.